Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
11 reviews, newest first
Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children
Cochraneheadline outcomes only
6 findings
Low molecular weight heparin for prevention of microvascular occlusion in digital replantation
Cochraneheadline outcomes only
14 findings
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery
Cochraneheadline outcomes only
10 findings
Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
Cochraneheadline outcomes only
5 findings
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
Cochraneheadline outcomes only
6 findings
Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism
Cochraneheadline outcomes only
3 findings
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
Cochraneheadline outcomes only
6 findings
Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
Cochraneheadline outcomes only
3 findings
Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis
Cochraneheadline outcomes only
6 findings
Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease
Cochraneheadline outcomes only
18 findings
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement
Cochraneheadline outcomes only
8 findings